U.S. Food and Drug Administration; United States Food and Drug Administration; FDA; Food and Drug Administration (FDA); Food and Drug Administration

Brain Supplements: Do They Really Work? 🧠

by

The $80 Billion Brain Boost Gamble: Are Supplements Worth the Risk? Nearly one in four adults over 65 experience cognitive impairment, driving a booming $80 billion market for brain health … Read More

Ketamine for Pain: FDA Approves New Post-Surgery Treatment

by

Ketamine’s FDA Approval: A Pain Relief Breakthrough Signaling a Broader Psychedelic Shift Despite a winding path to approval, the FDA’s green light for PharmaTher Holdings’ ketamine product, KETARx, for post-surgical … Read More

FDA Greenlights Zongertinib for Patients with HER2-Mutated Non-Small Cell Lung Cancer (NSCLC)

by

FDA approves Zongertinib: First Oral Targeted Therapy for HER2-Mutant Lung Cancer Table of Contents 1. FDA approves Zongertinib: First Oral Targeted Therapy for HER2-Mutant Lung Cancer 2. What are the … Read More

Glioma Breakthrough: FDA Approves New Aggressive Cancer Drug

by

A New Dawn for Diffuse Glioma: Dordaviprone’s Approval Signals a Shift in Treatment and a Billion-Dollar Bet on Immunometabolism For patients diagnosed with H3 K27M-mutant diffuse glioma – a particularly … Read More

Finerenone Expansion: FDA Broadens Heart Failure Approval

by

here are a few article options for archyde.com, leveraging the provided data about finerenone, focusing on different angles that might appeal to their audience. Option 1: Focus on the New … Read More

FDA Approves First MAS in Still Disease Treatment

by

FDA Greenlights First Treatment for Macrophage Activation Syndrome Related to Still’s Disease Table of Contents 1. FDA Greenlights First Treatment for Macrophage Activation Syndrome Related to Still’s Disease 2. Breakthrough … Read More

HIV PrEP & Alcohol Use Disorder: A Concerning Link

by

Alarming link Between PrEP Use and Alcohol Use Disorder Unveiled in New Study Table of Contents 1. Alarming link Between PrEP Use and Alcohol Use Disorder Unveiled in New Study … Read More

FDA Rejects Pfizer’s Talzenna Biomarker-Free Approval

by

Fda Panel Rejects Pfizer’s Ambition To Broaden Prostate Cancer Drug Use, Citing Weak Data Washington D.C. – A Us Food And Drug Administration (Fda) advisory panel has cast doubt on … Read More